Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-08-15 Purchase |
2022-08-17 4:45 pm |
OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO |
3,000 | $15.43 | $46,290 | 3,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-15 Tax Withholding |
2025-02-20 1:40 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO |
2,156 | $6.64 | 95,139 (Direct) |
View |
| 2024-12-23 Option Award |
2024-12-27 5:00 pm |
2025-12-23 2027-12-23 |
OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO |
119,150 | $0 | 175,037 (Direct) |
View |
| 2024-02-15 Option Award(A) |
2024-12-27 4:38 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO |
0 | $0 | 33,365 (Direct) |
View |
| 2024-12-19 Tax Withholding |
2024-12-20 7:46 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO |
1,316 | $4.75 | 47,761 (Direct) |
View |
| 2024-12-19 Exercise |
2024-12-20 7:46 pm |
N/A 2026-12-19 |
OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO |
5,237 | $0 | 47,761 (Direct) |
View |
| 2024-10-11 Exercise |
2024-10-15 4:53 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO |
8,222 | $0 | 33,366 (Direct) |
View |
| 2024-10-11 Tax Withholding |
2024-10-15 4:53 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO |
2,066 | $6.63 | 33,366 (Direct) |
View |
| 2024-10-03 Exercise |
2024-10-07 9:30 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO |
16,622 | $0 | 43,793 (Direct) |
View |
| 2024-10-03 Tax Withholding |
2024-10-07 9:30 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO |
4,177 | $7.83 | 43,793 (Direct) |
View |
| 2024-02-15 Option Award |
2024-04-24 10:16 am |
N/A N/A |
OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO |
7,083 | $0 | 14,765 (Direct) |
View |
| 2023-10-11 Exercise(A) |
2024-04-22 08:37 am |
N/A N/A |
OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO |
8,221 | $0 | 28,034 (Direct) |
View |
| 2022-10-11 Tax Withholding(A) |
2024-04-22 08:31 am |
N/A N/A |
OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO |
3,539 | $15.17 | 7,682 (Direct) |
View |
| 2023-12-19 Option Award |
2024-02-21 6:24 pm |
N/A 2026-12-19 |
OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO |
31,422 | $0 | 31,422 (Direct) |
View |
| 2022-10-11 Exercise |
2023-10-12 2:18 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO |
22,597 | $0 | 54,202 (Direct) |
View |
| 2023-10-11 Tax Withholding |
2023-10-12 2:18 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO |
2,066 | $7.15 | 54,202 (Direct) |
View |
| 2023-10-03 Exercise |
2023-10-06 2:47 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO |
16,662 | $0 | 50,432 (Direct) |
View |
| 2023-10-03 Tax Withholding |
2023-10-06 2:47 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO |
4,117 | $7.06 | 50,432 (Direct) |
View |
| 2022-10-11 Tax Withholding |
2023-03-30 12:19 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO |
6,539 | $15.17 | 21,125 (Direct) |
View |
| 2022-10-11 Exercise |
2023-03-30 12:19 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO |
8,221 | $0 | 21,125 (Direct) |
View |
| 2022-10-03 Option Award |
2022-10-05 1:17 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO |
147,504 | $0 | 147,504 (Direct) |
View |
| 2021-10-11 Option Award |
2021-10-13 4:45 pm |
N/A N/A |
OptimizeRx Corp | OPRX | Stelmakh Edward COO and CFO |
49,855 | $0 | 49,855 (Direct) |
View |
Ownership |
2021-10-12 08:15 am |
N/A N/A |
OptimizeRx Corp | OPRX | Stelmakh Edward COO and CFO |
0 | $0 | 0 (Direct) |
View |